BSEBoard Meeting6d ago · 27 Aug 2026, 06:39 pm

Gujarat Themis Biosyn Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/09/2026 ,inter alia, to consider and approve Please refer to the intimation ....

Gujarat Themis Biosyn Ltd · 506879

✦ AI SummaryFundraise

Gujarat Themis Biosyn Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/09/2026, inter alia, to consider and approve raising funds through issue of equity shares and/or convertible warrants through preferential issue on a private placement basis.

Analysis Scores

Earnings Impact5/10
Growth Catalyst6/10
Governance Concern2/10
Regulatory Risk3/10
Balance Sheet Risk4/10
Liquidity Impact8/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Gujarat Themis Biosyn Ltd - 506879 - Board Meeting Intimation for Intimation Of The Board Meeting

Attachments (1)

📄

238b45d6-121a-4b1d-ae10-f5ca1d5f41de.pdf

pdf

Download →
View document text
GUJARAT THEMIS BIOSYN LIMITED CIN: L24230GJ1981PLC004878 REGD. OFFICE &FACTORY: 69/C GIDC INDUSTRIAL ESTATE, VAPI – 396 195, DIST. VALSAD, GUJARAT, INDIA TEL: 0260-2430027 / 2400639 E-mail:hrm@gtbl.in.net GTBL/BSE/NSE/2026-27/55 27th August 2026 Listing Department Department of Corporate Services National Stock Exchange of India Limited BSE Limited Exchange Plaza, C-1, Block-G Phiroze Jeejeebhoy Towers, Dalal Street Bandra Kurla Complex Mumbai 400001 Bandra East, Mumbai 400051 Symbol: GUJTHEM Scrip Code: 506879 Dear Sir/Madam, Sub.: Intimation for Board Meeting pursuant to the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015. Dear Sir/Madam Pursuant to provisions of Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that a meeting of the Board of Directors of the Company is scheduled on 1st September 2026, inter alia, to approve raising funds through issue of equity shares and/or convertible warrants through preferential issue on a private placement basis, in accordance with the provisions of the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018 and the Companies Act, 2013, subject to necessary approvals including approval of the Shareholders of the Company and stock exchanges. Further, in terms of the "Code of Conduct for Monitoring and Prevention of Insider Trading” adopted by the Company under the SEBI (Prohibition of Insider Trading) Regulations, 2015, the Trading Window for dealing in the equity shares of the Company shall remain closed for all the concerned Designated Persons and their immediate relatives till the end of 48 hours after the outcome of the meeting is announced. Thanking you Yours faithfully For Gujarat Themis Biosyn Limited Vineet Gawankar Company Secretary & Compliance Officer MUMBAI OFFICE: Themis House, 11/12 Udyog Nagar, S.V Road, Goregaon (West), Mumbai – 400 104 Tel: 91-22-67607080 / 28757836 Fax: 28746621 / 67607019; E-mail: gtblmumbai@gtbl.in Website Address: www.gtbl.in